NO179504C - Legemiddel i form av en tablett inneholdende diritromycin - Google Patents

Legemiddel i form av en tablett inneholdende diritromycin

Info

Publication number
NO179504C
NO179504C NO921617A NO921617A NO179504C NO 179504 C NO179504 C NO 179504C NO 921617 A NO921617 A NO 921617A NO 921617 A NO921617 A NO 921617A NO 179504 C NO179504 C NO 179504C
Authority
NO
Norway
Prior art keywords
drug
tablet containing
dirithromycin
containing dirithromycin
tablet
Prior art date
Application number
NO921617A
Other languages
English (en)
Norwegian (no)
Other versions
NO921617L (no
NO921617D0 (no
NO179504B (no
Inventor
James Michael Greene
Holly Marie Hankins
Gregory Alan Stephenson
David Dale Wirth
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO921617D0 publication Critical patent/NO921617D0/no
Publication of NO921617L publication Critical patent/NO921617L/no
Publication of NO179504B publication Critical patent/NO179504B/no
Publication of NO179504C publication Critical patent/NO179504C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Formation And Processing Of Food Products (AREA)
NO921617A 1991-04-29 1992-04-27 Legemiddel i form av en tablett inneholdende diritromycin NO179504C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69284291A 1991-04-29 1991-04-29

Publications (4)

Publication Number Publication Date
NO921617D0 NO921617D0 (no) 1992-04-27
NO921617L NO921617L (no) 1992-10-30
NO179504B NO179504B (no) 1996-07-15
NO179504C true NO179504C (no) 1996-10-23

Family

ID=24782254

Family Applications (2)

Application Number Title Priority Date Filing Date
NO921617A NO179504C (no) 1991-04-29 1992-04-27 Legemiddel i form av en tablett inneholdende diritromycin
NO921616A NO180450C (no) 1991-04-29 1992-04-27 Farmasöytiske formuleringer og fremgangsmåte for fremstilling av form II diritromycin

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO921616A NO180450C (no) 1991-04-29 1992-04-27 Farmasöytiske formuleringer og fremgangsmåte for fremstilling av form II diritromycin

Country Status (27)

Country Link
EP (2) EP0511800B1 (enExample)
JP (2) JP3135672B2 (enExample)
KR (2) KR100194307B1 (enExample)
CN (2) CN1069197C (enExample)
AT (2) ATE144425T1 (enExample)
AU (2) AU655978B2 (enExample)
BR (2) BR9201540A (enExample)
CA (2) CA2067275C (enExample)
CY (2) CY1946A (enExample)
CZ (2) CZ282218B6 (enExample)
DE (2) DE69211220T2 (enExample)
DK (2) DK0511799T3 (enExample)
ES (2) ES2088098T3 (enExample)
FI (2) FI921876A7 (enExample)
GR (2) GR3020439T3 (enExample)
HK (2) HK153696A (enExample)
HU (2) HU213613B (enExample)
IE (2) IE76296B1 (enExample)
IL (2) IL101705A (enExample)
MX (2) MX9201946A (enExample)
MY (2) MY109498A (enExample)
NO (2) NO179504C (enExample)
NZ (2) NZ242506A (enExample)
RU (2) RU2070203C1 (enExample)
TW (2) TW216399B (enExample)
YU (2) YU44392A (enExample)
ZA (2) ZA922776B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW271400B (enExample) * 1992-07-30 1996-03-01 Pfizer
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
PT915899E (pt) * 1996-07-29 2004-11-30 Abbott Lab Preparacao da forma cristalina ii da eritromicina
JP2001501207A (ja) * 1996-09-24 2001-01-30 イーライ・リリー・アンド・カンパニー コーティングされた粒子製剤
RU2147234C1 (ru) * 1999-03-09 2000-04-10 Жемчугов Владислав Евгеньевич Препарат для профилактики и лечения особо опасных инфекционных заболеваний
US6390690B1 (en) 2000-05-17 2002-05-21 3M Innovative Properties Company Fiber optic connector for coupling devices on intersecting planes
RU2212242C1 (ru) * 2001-12-24 2003-09-20 Закрытое акционерное общество "Брынцалов-А" Антибиотик сумазид
MX2009005977A (es) * 2006-12-05 2009-06-17 Pfizer Polimorfos de motilida.
CN102145008B (zh) * 2010-12-29 2013-06-05 辰欣药业股份有限公司 一种地红霉素药物组合物及其制备方法
CN107151261B (zh) * 2017-06-09 2020-06-12 广州大光制药有限公司 一种地红霉素化合物的晶型及其结晶制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT342770B (de) * 1975-04-07 1978-04-25 Thomae Gmbh Dr K Verfahren zur herstellung neuer erythromycinderivate
DE2515075C2 (de) * 1975-04-07 1985-10-24 Dr. Karl Thomae Gmbh, 7950 Biberach Erythromycinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0184921A3 (en) * 1984-12-08 1986-10-29 Beecham Group Plc Erythromycin derivatives
DE3524572A1 (de) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
FI921876A0 (fi) 1992-04-27
FI921877A0 (fi) 1992-04-27
EP0511800B1 (en) 1996-10-23
MX9201944A (es) 1992-11-01
CN1069197C (zh) 2001-08-08
IL101705A (en) 1996-01-31
AU1525792A (en) 1992-11-05
DE69211220T2 (de) 1996-11-07
ZA922776B (en) 1993-10-15
KR920019364A (ko) 1992-11-19
CA2067275C (en) 2002-11-26
BR9201540A (pt) 1992-12-01
DE69211220D1 (de) 1996-07-11
ES2088098T3 (es) 1996-08-01
YU44492A (sh) 1994-06-24
MY114226A (en) 2002-09-30
KR100194307B1 (ko) 1999-06-15
HK153696A (en) 1996-08-16
RU2070203C1 (ru) 1996-12-10
ZA922777B (en) 1993-10-15
IL101704A0 (en) 1992-12-30
CY1946A (en) 1992-04-27
CS127792A3 (en) 1992-11-18
KR920019365A (ko) 1992-11-19
NO921617L (no) 1992-10-30
FI921876L (fi) 1992-10-30
NO921616L (no) 1992-10-30
DK0511800T3 (da) 1997-04-21
HUT62595A (en) 1993-05-28
NO921617D0 (no) 1992-04-27
IL101704A (en) 1998-02-22
TW315371B (enExample) 1997-09-11
CY1975A (en) 1997-09-05
NO180450B (no) 1997-01-13
NZ242505A (en) 1993-06-25
IE76296B1 (en) 1997-10-08
IL101705A0 (en) 1992-12-30
JPH05117289A (ja) 1993-05-14
JPH05117154A (ja) 1993-05-14
HU9201398D0 (en) 1992-07-28
AU655978B2 (en) 1995-01-19
BR9201541A (pt) 1992-12-01
TW216399B (enExample) 1993-11-21
ATE138924T1 (de) 1996-06-15
HU215917B (hu) 1999-03-29
KR100193742B1 (ko) 1999-06-15
HUT63956A (en) 1993-11-29
ATE144425T1 (de) 1996-11-15
HU9203168D0 (en) 1992-12-28
FI101795B (fi) 1998-08-31
CN1066186A (zh) 1992-11-18
JP3333545B2 (ja) 2002-10-15
FI101795B1 (fi) 1998-08-31
CA2067274A1 (en) 1992-10-30
DE69214710T2 (de) 1997-03-13
EP0511799B1 (en) 1996-06-05
YU44392A (sh) 1994-12-28
FI921877L (fi) 1992-10-30
FI921876A7 (fi) 1992-10-30
JP3135672B2 (ja) 2001-02-19
CZ282218B6 (cs) 1997-06-11
NO180450C (no) 1997-04-23
AU1525592A (en) 1992-11-05
MX9201946A (es) 1992-11-01
IE921345A1 (en) 1992-11-04
IE921346A1 (en) 1992-11-04
CA2067275A1 (en) 1992-10-30
MY109498A (en) 1997-02-28
CN1066270A (zh) 1992-11-18
CZ282021B6 (cs) 1997-04-16
GR3020439T3 (en) 1996-10-31
HU213613B (en) 1997-08-28
EP0511800A1 (en) 1992-11-04
NZ242506A (en) 1993-09-27
NO921616D0 (no) 1992-04-27
RU2045953C1 (ru) 1995-10-20
IE74885B1 (en) 1997-08-13
HK215096A (en) 1996-12-13
DE69214710D1 (de) 1996-11-28
ES2093779T3 (es) 1997-01-01
AU646734B2 (en) 1994-03-03
CA2067274C (en) 2002-10-15
NO179504B (no) 1996-07-15
CN1030611C (zh) 1996-01-03
GR3021706T3 (en) 1997-02-28
CS127692A3 (en) 1992-11-18
EP0511799A1 (en) 1992-11-04
DK0511799T3 (da) 1996-06-24

Similar Documents

Publication Publication Date Title
NO930484D0 (no) Medikamentutleveringsanordning
FI930737A7 (fi) Asialoglykoproteiiniin sidottu lääkeaine
FI921060A0 (fi) Farmaceutiska aerosolformuleringar.
FI922252A0 (fi) Farmaceutisk sammansaettning.
FI922316A0 (fi) Farmaceutisk sammansaettning.
DK0616523T3 (da) Lægemidler
NO923127L (no) Farmasoeytisk kombinasjonsformulering
FI924456A7 (fi) Lääke
FI893835L (fi) Laekemedel.
DE69218727D1 (de) Medikamentenbehälter
FI921877A0 (fi) Farmaceutiska foereningar.
FI921785A0 (fi) Farmaceutisk foerening.
FI921786A0 (fi) Farmaceutisk foerening.
MX9205375A (es) Nuevos derivados de bencilamina y el medicamento que los contienen.
MX9201791A (es) Medicamentos.
ES1018109Y (es) Chupete tentetieso.
NO921923D0 (no) Medikamentutleveringsanordning
NO922105D0 (no) Medikamentutleveringsanordning